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Peripherally inserted central catheter usage
patterns and associated symptomatic upper
extremity venous thrombosis
Timothy K. Liem, MD,a Keenan E. Yanit, BS,a Shannon E. Moseley, BA,a Gregory J. Landry, MD,a
Thomas G. DeLoughery, MD,b Claudia A. Rumwell, RN, RVT,a Erica L. Mitchell, MD,a and
Gregory L. Moneta, MD,a Portland, Ore
Objectives: Peripherally inserted central catheters (PICCs) may be complicated by upper extremity (UE) superficial (SVT)
or deep venous thrombosis (DVT). The purpose of this study was to determine current PICC insertion patterns and if any
PICC or patient characteristics were associated with venous thrombotic complications.
Methods: All UE venous duplex scans during a 12-month period were reviewed, selecting patients with isolated SVT or
DVT and PICCs placed <30 days. All UE PICC procedures during the same period were identified from an electronic
medical record query. PICC-associated DVTs, categorized by insertion site, were compared with all first-time UE PICCs
to determine the rate of UE DVT and isolated UE SVT. Technical and clinical variables in patients with PICC-associated
UE DVT also were compared with 172 patients who received a PICC without developing DVT (univariable and
multivariable analysis).
Results:We identified 219 isolated UE SVTs and 154 UE DVTs, with 2056 first-time UE PICCs placed during the same
period. A PICC was associated with 44 of 219 (20%) isolated UE SVTs and 54 of 154 UE DVTs (35%). The rates of
PICC-associated symptomatic UE SVTwere 1.9% for basilic, 7.2% for cephalic, and 0% for brachial vein PICCs. The rates
of PICC-associated symptomatic UE DVT were 3.1% for basilic, 2.2% for brachial, and 0% for cephalic vein PICCs (2
P < .001). Univariate analysis of technical and patient variables demonstrated that larger PICC diameter, noncephalic
insertion, smoking, concurrent malignancy, diabetes, and older age were associated with UE DVT (P < .05). Multivari-
able analysis showed larger catheter diameter and malignancy were the only variables associated with UE DVT (P< .05).
Conclusions: The incidence of symptomatic PICC-associated UE DVT is low, but given the number of PICCs placed each
year, they account for up to 35% of all diagnosed UE DVTs. Larger-diameter PICCs and malignancy increase the risk for
DVT, and further studies are needed to evaluate the optimal vein of first choice for PICC insertion. (J Vasc Surg 2012;
55:761-7.)
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rPeripherally inserted central catheters (PICCs) are a
convenient alternative to central venous catheters (CVCs)
in patients who require long-term intravenous access. They
may be placed at the patient’s bedside and do not have
some of the risks that accompany CVC insertion. However,
PICC usage may be complicated by the development of
upper extremity (UE) isolated superficial venous thrombo-
sis (SVT) as well as deep venous thrombosis (DVT). Al-
though the natural history of these catheter-associated UE
DVTs is not well studied, these complications remain clin-
ically relevant.
The American College of Chest Physicians (ACCP) has
recommended that patients with UE DVT in association
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doi:10.1016/j.jvs.2011.10.005ith an indwelling CVC receive at least 3 months of anti-
hrombotic therapy.1 In addition, hospital-associated DVT
as garnered increasing attention as a marker of hospital
uality, and the Association for Healthcare Research and
uality (AHRQ) has selected postoperative pulmonary
mbolism (PE) and DVT as key hospital level patient safety
ndicators.2 The AHRQ includes DVT of UE veins (sub-
lavian, axillary, and internal jugular) and does not exclude
hrombosis secondary to indwelling CVCs.
The purpose of this study was to determine current
atterns of PICC placement and to determine if any clinical
r technical variables were associated with a higher risk for
ymptomatic UE DVT.
ETHODS
This study was approved by the Institutional Review
oard at Oregon Health and Science University (OHSU).
e performed a retrospective record review, comparing the
ates of symptomatic venous thrombosis with the total
umber of PICCs placed at our institution during the same
nterval.
All UE venous duplex scans performed during a 1-year
eriod (July 2008 to June 2009) were identified from a
uery of a prospectively maintained OHSU vascular labo-
atory database. We identified patients with a newly diag-
osed UE DVT or isolated UE SVT and selected those
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March 2012762 Liem et alwhose PICC placement occurred 30 days from the du-
plex examination. A PICC-associated isolated UE SVT was
defined as an SVT within the same vein as the recently
placed PICC. A PICC-associated UE DVT was defined as a
DVT in the same vein as, or a vein immediately adjacent to,
the recently placed PICC. Patients with PICC-associated
UE DVTs who had concurrent SVT were included in the
DVT group. If the patient had a prior DVT or isolated SVT
in the same arm as a subsequent PICC placement, that
patient was considered to have non–PICC-associated ve-
nous thrombosis.
The incidence of PICC-associated symptomatic UE
DVT was calculated as the total number of PICC-associated
DVTs, divided by the total number of UE PICCs placed
during the same period. Similarly, the incidence of PICC-
associated isolated SVT was determined by dividing by the
total number of UE PICCs placed.
An electronic medical record query (Epic Systems
Corp, Verona, Wisc) was performed to identify all inpatient
and outpatient PICC procedures during the same 1-year
interval. A retrospective review was performed to identify
the patient age and sex and insertion date and site (right vs
left, basilic vein, brachial vein, cephalic vein, other).
The number of PICC-associated UE DVTs and iso-
lated UE SVTs were compared with the total number of
PICCs by the site of insertion. Only PICCs placed in UE
deep or superficial veins were included in this analysis. To
avoid within-subject correlation, only the first PICC placed
in each patient was used to perform the statistical analysis.
When the rates of SVT and DVT were compared by PICC
insertion site alone (basilic, brachial, and cephalic), a
three  three contingency table was evaluated with 2
analysis (P  .05). To determine if the insertion site corre-
lated more specifically with UE DVT, the insertion sites
were dichotomized, and two  two tables were created
(cephalic vs noncephalic insertion, basilic vs nonbasilic,
brachial vs nonbrachial, comparing them with DVT vs no
DVT) and analyzed with the Fisher exact test (two-tailed;
P  .05). Similarly, the insertion sites were analyzed to
determine any correlation with UE SVT. The insertion sites
were again dichotomized and used to compare two out-
comes (SVT vs no SVT) with Fisher exact test (two-tailed;
P  .05).
This study also sought to determine if any other tech-
nical and clinical risk factors were associated with the de-
velopment of PICC-associated UE DVT. Patients with a
PICC-associated UE DVT were compared with a control
group who developed PICC-associated isolated UE SVT
alone and a randomly selected group of patients who un-
derwent UE PICC placement during the same period but
were not diagnosed with a UE DVT or SVT. The total
number of patients in the control group was three times the
size of the PICC-associated UE DVT group.
Several technical variables regarding the PICC inser-
tion were evaluated, including insertion site (right vs left,
basilic vein, brachial vein, cephalic vein), PICC diameter
(F), lumen number, and PICC tip configuration (open tip
vs Groshong valve tip, Bard Access Systems, Inc, Salt Lake tity, Utah). Clinical variables evaluated included patient
ge and sex, concurrent or recent (6 months) malig-
ancy, concurrent infection, recent (30 days) surgery or
rauma, patient location (outpatient, inpatient, intensive
are unit), anticoagulant use before or after PICC inser-
ion, tobacco use, known thrombophilia, oral contraceptive
r hormonal replacement use, hypertension, diabetes, renal
nsufficiency or failure, hypercholesterolemia, and body
ass index. If the patient had a history of lower extremity
VT or contralateral UE DVT, this was recorded in the
atabase as a potential risk factor for subsequent PICC-
ssociated DVT.
The clinical characteristics were compared on a per-
atient basis, and these groups were compared using uni-
ariable analysis to determine any correlation with PICC-
ssociated UE DVT as the primary outcome variable (P 
05). Analysis was done with SPSS 14 software (SPSS Inc,
hicago, Ill). In addition, any clinical characteristics with a
alue of P  .2 were entered into a multivariable analysis
stepwise logistic regression model), and these results are
resented as odds ratios (ORs) with 95% confidence inter-
als (CIs). Lastly, the thrombosis-associated PICC dwell
ime was calculated as the number of days between the
ICC insertion and the diagnosis of a UE DVT or SVT.
he total PICC dwell time in patients who never developed
thrombotic complication could not be calculated accu-
ately because the date of PICC removal was not regularly
ocumented in the medical records.
Duplex ultrasound imaging was used to confirm the
resence of clinically suspected DVT or isolated SVT ac-
ording to standard diagnostic criteria. These include non-
ompressibility of the vein, presence of visible thrombus,
nd lack of Doppler-detected venous flow. Occasionally,
ig 1. A grayscale duplex image of a left subclavian vein shows a
isible peripherally inserted central catheter (PICC) and surround-
ng deep venous thrombus (DVT). This patient had undergone
asilic vein PICC placement 3 days before this study.he PICC and the surrounding thrombus were readily
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Volume 55, Number 3 Liem et al 763visualized (Fig 1). Most PICC procedures were performed
by a team of eight PICC insertion nurses, using a variety of
catheter configurations from a single source (Bard Access
Systems Inc). The lumen number and minimum catheter
diameter were determined by the requesting physician or
team. The insertion site was determined by the PICC
nurses after a preliminary ultrasound scan of the upper
extremity veins performed by the insertion team.
These procedures were performed with ultrasound
guidance (Sonosite Inc, Bothell, Wash, and Bard Access
Systems Inc) and sterile technique at the patient’s bedside.
Some procedures were performed with the assistance of a
noninvasive navigation system using magnetic fields gener-
ated by a preloaded PICC stylet (Sherlock Tip Location
System, Bard Access Systems Inc). Catheter position was
confirmed by postprocedural chest X-ray imaging. PICCs
inserted into blood vessels other than UE veins were not
included in our statistical analysis.
RESULTS
During the 12-month period, 831 UE venous duplex
scans were performed in 690 patients, identifying 373 scans
positive for DVT or isolated SVT. A total of 154 UE DVTs
were diagnosed in 138 patients, and 57 PICC-associated
UE DVTs were identified in 54 patients. Forty-eight
PICC-associated UE DVTs occurred in patients with
basilic vein PICCs (84%), and nine PICC-associated UE
DVTs occurred with brachial vein PICCs (16%). No DVTs
were associated with PICCs inserted via the cephalic vein. A
total of 219 isolated SVTs were detected 192 patients, with
44 PICC-associated SVTs in 42 patients, of which 30 (68%)
occurred with basilic-inserted PICCs and 14 (32%) with
cephalic-inserted PICCs. There were no isolated UE SVTs
in association with a brachial vein insertion site. PICC-
associated DVTs accounted for 37% of all UE DVTs and
PICC-associated SVTs accounted for 20% of all isolated
UE SVTs diagnosed at our institution during this 12-
month period.
PICC insertion site vs SVT and DVT. The elec-
tronic medical record query identified 2638 PICCs placed
during the same period. PICC insertion sites were basilic
vein in 1744, brachial vein in 450, and cephalic vein in 209,
with 235 PICCs placed in other locations. These latter
PICC insertion sites included superficial veins in the scalp,
the great saphenous, femoral, popliteal, jugular, and um-
bilical veins, and the umbilical arteries. These less common
catheter insertion sites were typically used in pediatric and
neonatal patients, who were an average age of 2.25 years
(range, 0-13 years). This latter group of patients was not
included in our statistical analysis. When repeat PICC
insertion procedures were excluded from the analysis to
minimize within-subject correlation, the first-time UE
PICC insertion sites were basilic vein in 1459, brachial vein
in 403, and cephalic vein in 194.
Table I lists the adjusted total number of first-time
PICCs placed in UE veins and the PICC-associated UE
DVTs and isolated SVTs on a per-patient basis, exclud-
ing repeat PICC procedures. Overall, the rate of PICC- cssociated UE DVT was 2.6% in this series. Comparisons by
he vein of insertion showed a DVT rate of 3.1% for patients
eceiving a basilic vein PICC and 2.2% for those receiving a
rachial vein PICC. However, there were no identifiable
ostprocedural DVTs in patients with cephalic-inserted
ICCs. PICC-associated UE SVT occurred in 1.9% of
atients who received a basilic vein PICC and in 7.2%
f patients who received a cephalic vein PICC. As expected,
o episodes of isolated UE SVT occurred when a PICC was
nserted into a brachial vein. A three  three 2 analysis
emonstrated a statistically significant difference between
he three insertion sites in the development of DVT or SVT
P  .001).
When insertion sites were dichotomized to determine
ny correlation with UE DVT, basilic vein insertion was
ssociated with a 3.1% rate of DVT vs 1.5% with nonbasilic
ein insertion (Fisher exact; P.047). Cephalic vein inser-
ion was associated with a 0% rate of DVT vs 2.9% for
oncephalic vein insertion (Fisher exact; P .008). When
he incidence of isolated UE SVT was evaluated, cephalic
ein insertion was associated with a 7.2% rate of isolated
VT vs 1.5% for noncephalic insertion (Fisher exact; P 
001). Brachial vein insertion was associated with a 0% rate
f SVT vs 2.5% for nonbrachial PICC insertion (Fisher
xact; P  .001; Table I).
Univariable and multivariable analysis of technical
nd clinical variables. The technical characteristics of the
ICCs and the clinical variables of the patients who re-
eived PICCs are listed in Table II. The diameter in 92.7%
f PICCs was 4F or 5F, and 98.5% were single-lumen or
ouble-lumen. Sixty-four percent of patients had recent
urgery or trauma (30 days), 27% had concurrent or
ecent malignancy, and 69% had a concurrent infection.
enal insufficiency or dialysis-dependent renal failure was
resent in 21%. PICC-associated DVTs were diagnosed an
verage of 9.56 days after PICC insertion, and SVTs were
iagnosed an average of 6.0 days after PICC insertion.
ocumentation on the timing of PICC removal was in-
omplete, and the total PICC dwell time in patients who
ere never diagnosed with a DVT or SVT could not be
able I. A, The rates of peripherally inserted central
atheter (PICC)-associated deep venous thrombosis
DVT), and isolated superficial venous thrombosis (SVT),
ased on upper extremity (UE) insertion site
ariable
PICC vein insertion site
Basilic Brachial Cephalic
No. (%) No. (%) No. (%)
otal PICCsa 1459 403 194
ICC-associated thrombosis
Symptomatic DVT 45 (3.1) 9 (2.2) 0 (0)
Isolated symptomatic SVT 28 (1.9) 0 (0) 14 (7.2)
hi-square analysis of three  three contingency table demonstrated a
ignificant difference between insertion sites (P  .001).
Only the first PICC per patient was used in the statistical analysis. PICCs
laced in non-UE veins were excluded from this analysis.alculated from our data.
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March 2012764 Liem et alIn patients who developed PICC-associated UE DVT,
11% and 28% were receiving therapeutic or prophylactic
doses of anticoagulation, respectively, before the DVT
diagnosis. Once the DVT was diagnosed, the number of
patients treated with therapeutic anticoagulation increased
from 28% to 56%, and 44% continued to receive prophylac-
tic anticoagulation or no anticoagulation, even after the
diagnosis of a PICC-associated UE DVT. The percentage
of patients with PICC-associated UE SVT who were receiv-
ing therapeutic anticoagulation before and after the PICC
insertion remained similar, at 14% and 16%, respectively.
Univariable analysis demonstrated that UE DVT oc-
currence was more likely in patients with a catheter diame-
ter of 5F (P  .002), a multilumen PICC (P  .004),
and a noncephalic vein PICC insertion site (P  .043). A
Table I. B, Insertion sites were dichotomized to determin
superficial venous thrombosis (SVT).a
Incidence Site No. (%)
Symptomatic UE DVT Basilic 45 (3.1)
Cephalic 0 (0.0)
Brachial 9 (2.2)
Symptomatic UE SVT Basilic 28 (1.9)
Cephalic 14 (7.2)
Brachial 0 (0.0)
aFisher exact test (two-tailed) was used for the dichotomized two  two tab
Table II. Technical characteristics of peripherally
inserted central catheter (PICC) insertions and clinical
risk factors in patients who underwent PICC placement
PICC technical
variables
(n 226) %
Clinical variables
(n  226) %
PICC diameter
3F 4.30 Recent surgery 56
4F 19.70 Recent trauma 8.30
5F 73 Patient location
6F 1.30 Outpatient 3.6
Other 1.70 Inpatient 48.9
Lumen number Intensive care unit 47.5
Single 24.40 Malignancy 27
Double 74.10 Chemotherapy 19
Triple 1.50 Infection 69
Right insertion side 42 Hypertension 40
Tip configuration Diabetes 26
Groshong 71 Tobacco use
Open tip 29 Prior 27
Current 16
Thrombophilia 3.20
OCT/HRT 4
Renal insufficiency 18
Renal failure, dialysis 3
Hypercholesterolemia 18
BMI, kg/m2 26.6  9.21a
BMI, Body mass index; HRT, hormonal replacement therapy; OCT, oral
contraceptive.
aMean data  standard deviation are presented.significantly higher UE DVT incidence was seen in patients tho smoked (P  .033), took oral contraceptives or hor-
onal replacement therapy (P  .001), received chemo-
herapy (P .001), had concurrent or recent malignancy
P  .021), diabetes (P  .001), and older age (P 
029; Table III, A). In the multivariable logistic regression
nalysis, the technical and clinical variables that were iden-
ified as significant risk factors for a PICC-associated DVT
ere catheter diameter 5F (OR, 3.9; 95% CI, 1.1-13.9)
nd malignancy (OR, 4.1; 95% CI, 1.9-8.9; Table III, B).
iabetes was of borderline significance in the multivariable
nalysis (OR, 2.5; 95% CI, 0.98-6.3).
ISCUSSION
PICCs provide a convenient method of long-term in-
ravenous access and are associated with a high rate of
atient satisfaction compared with peripheral intravenous
atheters.3 However, PICCs may be complicated by infec-
y association with deep venous thrombosis (DVT) or
Site No. (%) Pb
vs Nonbasilic 9 (1.5) .047
vs Noncephalic 54 (2.9) .008
vs Nonbrachial 45 (2.7) .728
vs Nonbasilic 14 (2.3) .606
vs Noncephalic 28 (1.5) .001
vs Nonbrachial 42 (2.5) .001
able III. A, Univariable analysis of technical and
linical variables related to peripherally inserted central
atheter (PICC)-associated upper extremity deep venous
hrombosis (DVT)
ariablea DVT (–) DVT () P
echnical
Catheter diameter5F 72.30 92.50 .002
Multilumen PICC 71 93 .004
Right-sided insertion 41 45 .592
Cephalic insertion site 24.10 0 .043
Groshong tip 72 70 .769
linical variable
Age, years 41.7  25.8 48.8  18.9 .029
Male gender 52 60 .298
Recent surgery 56 58 .751
Recent trauma 10 4 .209
Malignancy 23 39 .021
Chemotherapy 21 61 .001
Infection 73 74 .785
Hypertension 41 37 .554
Diabetes 18 52 .001
Tobacco 13 25 .033
Hormonal therapy 1.20 31 .001
Renal insufficiency/
failure
22 18 .714
Hypercholesterolemia 18 19 .813
Categoric data are presented as percentage and continuous data as mean
tandard deviation.e anion, dislodgement, catheter fracture with central venous
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Volume 55, Number 3 Liem et al 765migration, isolated UE SVT, UE DVT, Horner syndrome,
and even chylothorax.3-9 Of these, the more common
complications are infection and venous thrombosis. At our
institution, PICC-associated venous thrombosis accounted
for more than one-third of all UE DVTs and one-fifth of all
isolated UE SVTs during the 12-month study period.
Therefore, measures that minimize the incidence of PICC-
associated thrombosis should have a beneficial effect on the
overall rate of hospital-acquired venous thromboembolism.
Despite this significant prevalence, when accounting
for the total number of PICCs that are placed each year, the
overall incidence of PICC-associated UE DVT remains low
(2.6% in this study). This rate agrees closely with other large
retrospective studies and some prospective observational
studies documenting an incidence of UE DVT of 1.6% to
3.5% (Table IV).5,7,10-13 These events likely approximate
the number of patients with symptomatic PICC-associated
DVT, because routine venous duplex scanning was not
performed in all patients who received a PICC. Rather,
these scans more likely were performed to investigate the
presence of symptoms such as pain or edema.
In contrast, smaller prospective trials have demonstrated a
significantly higher incidence of DVT of 9.3% to 19.4%.3,14,15
Routine ultrasound screening or contrast venography were
performed in these latter studies, and most patients with
venous thrombotic complications were asymptomatic.
Whether asymptomatic CVC-associated DVT has the same
clinical relevance as symptomatic venous thrombosis remains
to be determined. A recently published prospective study
documented an even higher 20% rate of symptomatic venous
thrombosis and a 27% rate of UE DVT. However, the authors
only included patients with larger, 6F triple-lumen PICCs
inserted into basilic or brachial veins.16 Other publications
also have evaluated PICC-related venous thrombosis, but
with inconsistent inclusion criteria or no discrimination be-
tween DVT and SVT.6,17
When PICC insertion sites were compared with the
total number of first-time PICC placements, several pat-
terns emerged. The incidence of isolated UE SVT after
PICC insertion was 0% in the brachial vein and 7.2% in the
cephalic vein. The first of these observations seems intui-
tive: direct insertion of a PICC into a deep vein should
not contribute to SVT. The higher incidence of cephalic-
associated isolated SVTs may be related to the anatomic
characteristics of the cephalic vein. It tends to have a smaller
Table III. B, Multivariable logistic regression of
technical and clinical variables related to peripherally
inserted central catheter (PICC)-associated upper
extremity deep venous thrombosis (DVT)
Technical or clinical
variable OR (95% CI) P
Catheter diameter 5F 3.9 (1.1-13.9) .037
Malignancy 4.1 (1.9-8.9) .001
CI, Confidence interval; OR, odds ratio.diameter, fewer tributaries, and a more perpendicular inser- tion into the much larger axillary vein. The smaller cephalic
iameter, relative to the catheter size, also may contribute
o the higher rate of PICC-associated SVT (Fig 2).
When patients with PICC-associated DVT were com-
ared with the entire group who received a first-time UE
ICC, basilic vein PICCs were associated with a higher inci-
ence of UE DVT (3.1%), and cephalic vein PICCs were
ssociated with a lower incidence (0%). The basilic vein is
arger, often with multiple interconnecting branches, and has
more gradual confluence with the axillary vein. In contrast,
ephalic vein thrombi may be less likely to propagate into the
eep venous system due to the previously described anatomic
actors. PICCs inserted into the brachial veins had an interme-
iate incidence of UE DVT, not significantly different from
he nonbrachial vein group.
However, the cephalic cannot yet be recommended
s the vein of first choice for PICC insertion. Although
separate univariable comparison demonstrated that a
ephalic-inserted PICC was associated with a lower incidence
f DVT, this association did not remain significant in the
ultivariable analysis. This discrepancy may have several
xplanations. When comparing insertion site alone, pa-
ients with PICC-associated UE DVT were compared with
2000 patients without symptomatic DVT, increasing the
ikelihood of finding a true difference. The univariable and
ultivariable analyses were performed on a more limited
cale, with data from only 226 patients. A second explana-
ion may be the overall low number of cephalic PICC
nsertions in our series, accounting only for 8.7% of all
pper extremity PICCs. This low rate of cephalic-inserted
ICCs is common among numerous prior studies.
The univariable and multivariable analyses did identify
ther technical and clinical variables that were associated
ith the development of UE DVT. These included larger
atheter diameter (5F) and concurrent or recent malig-
ancy, characteristics that have also been identified as risk
actors for the development of PICC-associated DVT in
rior studies. Grove and Pevec10 described a strong rela-
ionship between PICC diameter and the development of
hrombosis, with thrombosis rates of 1% with 4F, 6.6% with
F, and 9.8% with 6F PICCs and no thrombosis with 3F
ICCs. A recent larger observational study demonstrated a
imilar correlation between catheter size and incidence of
VT (4F, 0.6%; 5F, 2.9%; and 6F, 8.8%).13 Several studies
hat did not demonstrate a relationship between PICC
iameter and venous thrombosis either did not assess PICC
iameter or used only single-diameter catheters.11,15,16
dditional risk factors for DVT that have been described
nclude previous venous thromboembolism and longer-
uration surgery.7,13
The efficacy of prophylactic anticoagulation for the
revention of PICC-associated UE DVT remains contro-
ersial. A small, prospective observational study of 56 pa-
ients demonstrated that anticoagulation was associated
ith a decreased rate of PICC-associated venous thrombo-
is, but the authors did not differentiate between the deep
nd superficial system.18 Our study demonstrated that an-
icoagulation did not confer any protective effect against
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March 2012766 Liem et alPICC-associated symptomatic UE DVT. The results of
other larger prospective studies regarding catheter throm-
boprophylaxis remain mixed, depending on whether pa-
tients were being assessed with routine duplex or veno-
graphic imaging, or for symptomatic venous thrombosis
only.19 Because the rate of symptomatic venous throm-
boembolism remains low, the most recent American Col-
Table IV. The incidence of peripherally inserted central ca
thrombosis (DVT) in prior retrospective and prospective tr
First author
PICCs
(No.)
PICC insertion
Site
Grove10 (2000) 813 Basilic
Cephalic
Other
Chemaly5 (2002) 2063 NR
Lobo7 (2009) 777 Basilic
Cephalic
Antecubital
Ong11 (2006) 2882 NR
Nash12 (2009) 376 NR
Evans13 (2010) 2014 Basilic
Brachial
Cephalic
Abdullah14 (2005) 26 Basilic
Brachial
Cephalic
Antecubital
Dubois15 (2007) 214 NR
Trerotola16 (2010) 50 Basilic
Brachial
Periard3 (2008) 31 Basilic or brachial
Current study 2056 Brachial
Basilic
Cephalic
CF, Cystic fibrosis; NR, not reported; SVT, superficial venous thrombosis.
Fig 2. A left upper extremity venogram demonstrates multiple
anastomoses between the basilic vein (black arrow), the brachial
vein, and the axillary vein. The cephalic vein is smaller, with
relatively fewer tributaries, and an arched insertion into the axillary
vein (white arrow).lege of Chest Physicians Evidence-Based Clinical Practice ruidelines (8th edition) recommend against routine throm-
oprophylaxis in patients with indwelling CVCs.20
This study also described the high prevalence of renal
nsufficiency or dialysis-dependent kidney failure (21%)
n patients receiving PICCs. The Vascular Access (2006)
ork Group published guidelines recommending that
ICCs not be placed in patients with kidney disease so
hat UE veins may be preserved for future dialysis access
ptions.21 A systematic method to screen patients for
enal disease at the time of referral for PICC insertion
hould be established. We are creating a standard proto-
ol in our institution to decrease the use of PICCs in
hese patients.
Our study had several limitations. As a retrospective
eview, our data probably underestimated the true number
f PICC-associated SVTs and DVTs because there was no
rotocol for systematic ultrasound screening at our institu-
ion. In addition, our definition, which limited the PICC-
ssociated DVTs to those occurring within 30 days of
nsertion, might have missed thrombotic complications
hat occurred beyond the 30-day window. However, this
ime limitation was introduced to remain consistent with
rior studies of catheter-related venous thrombosis.22,23
Also, patients with unsuccessful attempts at PICC
lacement were not assessed. Some additional patients
ight have developed a UE DVT as a result of trauma from
recently attempted PICC placement, and some PICC-
ssociated venous thromboses may have been diagnosed at
er (PICC)-associated upper extremity deep venous
Thrombosis
rate (%) Comment%
3.9 DVT and SVT Retrospective
1.6 DVT Retrospective
3.47 DVT Retrospective
.10 0.51 SVT
.90 1.03 PE
2.6 DVT Retrospective
3.7 DVT Retrospective, all CF
patients
3.00 Prospective observational
11.5 DVT Prospective
.60
.20
.20
9.3 DVT Prospective
20 symptomatic Prospective, all 6 Fr
58 all thrombosis
19.4 DVT Prospective
.60 2.6 DVT Retrospective
.70
.70thet
ials
65
16
19
90
5
4
74
23
3
54
7
19
19
64
36
72
18
8eferring institutions.
11
1
1
1
1
1
1
1
1
2
2
2
2
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Volume 55, Number 3 Liem et al 767Lastly, our retrospective study design did not control or
identify diagnostic biases, which might lead some clinicians
to perform more frequent venous duplex scanning in se-
lected higher-risk populations.
CONCLUSIONS
Despite these limitations, our data indicate that the
incidence of PICC-associated symptomatic UE DVT is
low. However, given the large number of PICCs placed
each year, they account for a significant percentage—37%
in our study—of the total number of UE DVTs at our
institution. Protocols which ensure the use of the smallest
possible catheter diameter should help decrease the inci-
dence. In addition, clinicians should maintain a higher
index of suspicion for PICC-associated UE DVT in patients
with malignancy and in patients who receive a larger-
diameter PICC.
Although some of our data suggest that cephalic-in-
serted PICCs might decrease the risk for DVT, further trials
are needed to identify the optimal vein of first choice before
widespread recommendations can be made. Lastly, screen-
ing for renal insufficiency should be routine in patients who
are candidates for PICC placement to maintain options for
future dialysis access.
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